awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37633396-7B10A540-90B3-486D-A2E2-3AC130664469
Q37633396-7B10A540-90B3-486D-A2E2-3AC130664469
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37633396-7B10A540-90B3-486D-A2E2-3AC130664469
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
P2860
Q37633396-7B10A540-90B3-486D-A2E2-3AC130664469
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37633396-7B10A540-90B3-486D-A2E2-3AC130664469
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cb0512be76d4831b66edd3993636ce72847c3dd5
P2860
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).